These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15542591)

  • 1. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
    Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
    J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.
    Ippel JH; de Haas CJ; Bunschoten A; van Strijp JA; Kruijtzer JA; Liskamp RM; Kemmink J
    J Biol Chem; 2009 May; 284(18):12363-72. PubMed ID: 19251703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.
    Postma B; Poppelier MJ; van Galen JC; Prossnitz ER; van Strijp JA; de Haas CJ; van Kessel KP
    J Immunol; 2004 Jun; 172(11):6994-7001. PubMed ID: 15153520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.
    Liu ZJ; Yang YJ; Jiang L; Xu YC; Wang AX; Du GH; Gao JM
    Acta Pharmacol Sin; 2011 Aug; 32(8):1038-44. PubMed ID: 21706042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.
    Haas PJ; de Haas CJ; Kleibeuker W; Poppelier MJ; van Kessel KP; Kruijtzer JA; Liskamp RM; van Strijp JA
    J Immunol; 2004 Nov; 173(9):5704-11. PubMed ID: 15494522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
    Wright AJ; Higginbottom A; Philippe D; Upadhyay A; Bagby S; Read RC; Monk PN; Partridge LJ
    Mol Immunol; 2007 Apr; 44(10):2507-17. PubMed ID: 17258808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.
    Nikiforovich GV; Baranski TJ
    Biochem Biophys Res Commun; 2009 Dec; 390(3):481-4. PubMed ID: 19799858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
    Haas PJ; de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA; Dijkstra K; Scheek RM; Fan H; Kruijtzer JA; Liskamp RM; Kemmink J
    J Mol Biol; 2005 Nov; 353(4):859-72. PubMed ID: 16213522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
    Mery L; Boulay F
    J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHIPS binds to the phosphorylated N-terminus of the C5a-receptor.
    Bunschoten A; Feitsma LJ; Kruijtzer JA; de Haas CJ; Liskamp RM; Kemmink J
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3338-40. PubMed ID: 20457523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.
    Gustafsson E; Haas PJ; Walse B; Hijnen M; Furebring C; Ohlin M; van Strijp JA; van Kessel KP
    BMC Immunol; 2009 Mar; 10():13. PubMed ID: 19284584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.
    Bunschoten A; Ippel JH; Kruijtzer JA; Feitsma L; de Haas CJ; Liskamp RM; Kemmink J
    Amino Acids; 2011 Feb; 40(2):731-40. PubMed ID: 20683629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.
    Waters SM; Brodbeck RM; Steflik J; Yu J; Baltazar C; Peck AE; Severance D; Zhang LY; Currie K; Chenard BL; Hutchison AJ; Maynard G; Krause JE
    J Biol Chem; 2005 Dec; 280(49):40617-23. PubMed ID: 16230349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
    Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
    J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
    Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
    J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, expression, cellular distribution, and role in chemotaxis of a C5a receptor in rainbow trout: the first identification of a C5a receptor in a nonmammalian species.
    Boshra H; Li J; Peters R; Hansen J; Matlapudi A; Sunyer JO
    J Immunol; 2004 Apr; 172(7):4381-90. PubMed ID: 15034053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered
    Sahoo AR; Mishra R; Rana S
    Sci Rep; 2018 Feb; 8(1):2955. PubMed ID: 29440703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies.
    Gustafsson E; Rosén A; Barchan K; van Kessel KP; Haraldsson K; Lindman S; Forsberg C; Ljung L; Bryder K; Walse B; Haas PJ; van Strijp JA; Furebring C
    Protein Eng Des Sel; 2010 Feb; 23(2):91-101. PubMed ID: 19959567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.